Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by MlCHENFELDER, J. D.
Right arrow Articles by THEYE, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MlCHENFELDER, J. D.
Right arrow Articles by THEYE, R. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 1971, Vol. 43, No. 7 630-637
© 1971 The Board of Management and Trustees of the British Journal of Anaesthesia

other

EFFECTS OF FENTANYL, DROPERIDOL, AND INNOVAR ON CANINE CEREBRAL METABOLISM AND BLOOD FLOW

J. D. MlCHENFELDER and R. A. THEYE

Mayo Clinic and Mayo Foundation (Section of Anes- thesiology), Rochester, Minnesota, U.S.A

The effects of droperidol and fentanyl given individually and in combination (Innovar) on the rate of cerebral oxygen consumption (CMRo,) and cerebral blood flow (c.b.f.) were studied in dogs anaesthetized with nitrous oxide (70 percent) and oxygen. Fentanyl (0.006 mg/kg) decreased both the CMRo, and the c.b.f. (mean decreases at 15 minutes were 18 per cent and 47 percent, respectively). The duration of effect was approximately 30 minutes. Droperidol (0.3 mg/kg) produced a decrease of 40 per cent in c.b.f. due primarily to a 30-40 per cent increase in cerebrovascular resistance, and this effect persisted for the period of observation (60 minutes). No significant change in CMRo, occurred after droperidol was administered. With the combination drug (Innovar), the effects were partially additive. After 15 minutes, CMRo, had decreased 23 per cent; c.b.f. had decreased 50 per cent; and cerebral vascular resistance had increased 85 per cent. After 30 minutes, the effects of Innovar were indistinguishable from those of droperidol alone. No significant changes occurred in the rate of cerebral glucose consumption or the oxygen-glucose index. The effect of increased and decreased Paooj on c.bi. after Innovar was compared widi that observed during halothane anaesthesia. With halothane, hypercapnia (Pacoi=60 tnm Hg) increased c.b.f. 40 per cent and hypocapnia (Pace = 20 mm Hg) decreased c.b.f. 40 per cent. Innovar at normocapnia reduced the c.b.f. 65 per cent. With hypercapnia, the c.bi. doubled, but with hypocapnia, little further reduction in c.b.f. occurred. It is concluded that droperidol is a potent cerebral vasoconstrictor, that this effect dominates when it is given in combination with fentanyl, that hypocapnia causes little further reduction in c.b.f., and that the reduction in c.bi. produced by Innovar is not accompanied by alterations in normal cerebral metabolic pathways


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.